PRMENasdaq

Prime Medicine, Inc.

Biological Products, (No Diagnostic Substances) · DE · CIK 1894562

Developing genetic medicines using Prime Editing to treat diseases driven by genetic alterations

red 8-K · 90d

$501M

Market cap

$3.72

Last close

+8.4%

+10.4%

5.3M

Volume

Price · last 39 sessions+7.2%

May 4L $2.70 · H $3.72Jun 29

Total filings

Jun 8, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance